21 July 2020 - The White House is considering one or more executive orders aimed at lowering drug prices that could come as soon as this week, prompting pushback from some GOP lawmakers and the powerful pharmaceutical industry.

One idea under discussion, sources say, is to link some U.S. drug prices to the lower prices paid overseas, an idea that is opposed by many Republicans, who see it as a price control that violates free-market principles.

The looming executive action comes a little more than three months from the election, on an issue that is key to voters.

Read The Hill article